Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-11-01 | Harmony Biosciences Holdings, Inc. | Sabater Juan A.
(Director) |
S | Common Stock | D | 4600000 | $30.30 - $30.30 | $139,391,500 |
2024-10-29 | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey
(CHIEF COMMERCIAL OFFICER) |
S | Common Stock | D | 21496 | $40.47 - $40.47 | $870,018 |
2024-10-29 | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey
(CHIEF COMMERCIAL OFFICER) |
M | Common Stock | A | 21496 | $24.00 - $24.00 | $515,904 |
2024-09-30 | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey
(CHIEF COMMERCIAL OFFICER) |
S | Common Stock | D | 35846 | $40.03 - $40.03 | $1,434,951 |
2024-09-30 | Harmony Biosciences Holdings, Inc. | Dierks Jeffrey
(CHIEF COMMERCIAL OFFICER) |
M | Common Stock | A | 35846 | $24.00 - $24.00 | $860,304 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |